Letters
Hormonal contraception and thrombosis
Any review must carefully weigh the available evidence
BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2250 (Published 16 April 2013) Cite this as: BMJ 2013;346:f2250- Dustin J Costescu, contraceptive advice research and education fellow1,
- Ashley Waddington, contraceptive advice research and education fellow1
- 1Department of Obstetrics and Gynaecology, Queen’s University, Kingston, ON, Canada K7L 2V7
- dustin.costescu{at}queensu.ca
Helmerhorst and Rosendaal’s recommendation that women prescribed oral contraceptives should receive levonorgestrel and 30 µg of ethinylestradiol is based on the observation that thrombosis risk is related to ethinylestradiol amount and progestogen type.1 Although interesting, this strategy is not adequately evidence based.
Retrospective database studies of contraception and thrombosis are often cited because they are inexpensive and can rapidly amass large datasets. Unfortunately, conclusions are …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.